Roche Holding Ltd ADR (RHHBY)

38.35
+0.24(+0.63%)
After Hours
38.35
0.00(0.00%)
- Delayed Data
  • Volume:
    2,617,396
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    38.11 - 38.40

RHHBY Overview

Prev. Close
38.11
Day's Range
38.11-38.4
Revenue
67.96B
Open
38.24
52 wk Range
37.32-53.86
EPS
17.8
Volume
2,617,396
Market Cap
283.16B
Dividend (Yield)
0.8068
(2.12%)
Average Vol. (3m)
1,379,942
P/E Ratio
18.43
Beta
0.208
1-Year Change
-18.47%
Shares Outstanding
801,094,291
Next Earnings Date
Apr 26, 2023
What is your sentiment on Roche Holding ADR?
or
Market is currently closed. Voting is open during market hours.

Roche Holding Ltd ADR Analysis

Roche Holding Ltd ADR Company Profile

Roche Holding Ltd ADR Company Profile

Employees
100920

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Read More

Analyst Price Target

Average47.80 (+24.64% Upside)
High48.00
Low47.60
Price38.35
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyNeutralSellSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell
  • it will go up: the chart formed an "bulllish doji star"
    1
    • This Is one and only real competitor in covid test from POLAND http://scopefluidics.com/scope-fluidics-is-developing-an-ultra-fast-covid-19-panel-for-its-pcrone-rapid-molecular-diagnostic-system/
      0
      • Roche just announced as the test pushed through for Covid 19 Tessting. Up Up Up!
        2
        • Jan 26, 2020 Sun $41.20 its GENE is dazzling as always focusing on breakthrough sciences
          0